Population assessed as % NK cells expressing…. | HIV patients | CMV+ controls | CMV− Controls | |||
---|---|---|---|---|---|---|
P a | R a | P | R | P | R | |
LIR-1 (MFI on NK cells) vs…. | ||||||
CD107a | 0.01 | 0.56 | 0.15 | 0.38 | 0.49 | 0.26 |
CD107a with K562 | 0.02 | 0.31 | 0.26 | 0.31 | 0.23 | 0.45 |
CD57 vs…. | ||||||
CD107a | 0.02 | 0.56 | 0.73 | 0.09 | 0.43 | −0.3 |
CD107a with K562 | 0.08 | 0.40 | 0.28 | −0.30 | 0.70 | 0.15 |
IFNγ | 0.10 | −0.41 | 0.06 | −0.48 | 0.61 | −0.2 |
IFNγ with K562 | 0.14 | −0.35 | 0.09 | −0.44 | 0.17 | 0.5 |
CD56loperforinhi | 0.001 | 0.72 | 0.28 | 0.29 | 0.49 | 0.27 |
CD56hiperforinlo | 0.004 | −0.64 | 0.86 | 0.05 | 0.64 | 0.23 |